✨ Medicines Notices
1 MARCH
NEW ZEALAND GAZETTE
531
Product:
Fluphenazine Decanoate Injection BP
Active Ingredient(s):
Fluphenazine decanoate 100mg/mL
Dosage Form:
Injection (depot)
New Zealand Sponsor:
Baxter Healthcare Limited
Manufacturer(s):
David Bull Laboratories Ltd, Mulgrave North, Victoria, Australia
Product:
Prograf
Active Ingredient(s):
Tacrolimus 0.5mg
Dosage Form:
Capsule
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturer(s):
Fujisawa Ireland Limited, Killorglin, Co Kerry, Ireland
Product:
Tofranil
Active Ingredient(s):
Imipramine hydrochloride 10mg
Dosage Form:
Coated tablet
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Novartis Pharma AG, Stein, Switzerland
Dated this 21st day of February 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go1378
Consent to the Distribution of New Related Products
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related products set out in the Schedule hereto:
Schedule
Product:
Vicks MediLoz (Cherry flavour)
Active Ingredient(s):
Cetylpyridinium chloride 0.0145%w/w
Dosage Form:
Lozenge
New Zealand Sponsor:
Procter & Gamble NPD Inc
Manufacturer(s):
PT Procter & Gamble Indonesia, Ujung Mentang, Jakarta, Indonesia
Product:
Vicks MediLoz (Lemon flavour)
Active Ingredient(s):
Cetylpyridinium chloride 0.02%w/w
Dosage Form:
Lozenge
New Zealand Sponsor:
Procter & Gamble NPD Inc
Manufacturer(s):
PT Procter & Gamble Indonesia, Ujung Mentang, Jakarta, Indonesia
Product:
Vicks MediLoz (Menthol)
Active Ingredient(s):
Cetylpyridinium chloride 0.0145%w/w
Dosage Form:
Lozenge
New Zealand Sponsor:
Procter & Gamble NPD Inc
Manufacturer(s):
PT Procter & Gamble Indonesia, Ujung Mentang, Jakarta, Indonesia
Product:
Vicks MediLoz (Orange flavour)
Active Ingredient(s):
Cetylpyridinium chloride 0.02%w/w
Dosage Form:
Lozenge
New Zealand Sponsor:
Procter & Gamble NPD Inc
Manufacturer(s):
PT Procter & Gamble Indonesia, Ujung Mentang, Jakarta, Indonesia
Dated this 21st day of February 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go1381
Classification of Medicines
Pursuant to section 106 (1) of the Medicines Act 1981, I, G. R. Boyd, Chief Advisor, Safety and Regulation, acting under delegated authority, hereby declare the following:
-
The medicines listed in Schedule 1 to this notice are classified as prescription medicines.
-
The medicines listed in Schedule 2 to this notice are classified as restricted medicines.
-
The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.
Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.
Unless specific reference is made otherwise, every reference applies also to medicines that are:
(a) Preparations and admixtures containing any substance listed in the notice;
(b) Salts and esters of any substance listed in the notice;
(c) Preparations or extracts of biological materials listed in the notice;
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 23
Gazette.govt.nz —
NZ Gazette 2001, No 23
✨ LLM interpretation of page content
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare21 February 2001
Medicines, Consent, Fluphenazine Decanoate Injection, Prograf, Tofranil
- G. R. Boyd, Chief Advisor, Safety and Regulation
🏥 Consent to the Distribution of New Related Products
🏥 Health & Social Welfare21 February 2001
Medicines, Consent, Vicks MediLoz, Lozenge
- G. R. Boyd, Chief Advisor, Safety and Regulation
🏥 Classification of Medicines
🏥 Health & Social Welfare21 February 2001
Medicines, Classification, Prescription, Restricted, Pharmacy-only
- G. R. Boyd, Chief Advisor, Safety and Regulation